Transient ischemic attack (TIA) is neurological dysfunction which is caused by loss of blood flow in the brain, spinal cord, or retina. The primary causes of transient ischemic attack are loss of blood supply to brain and which may occur due to various reasons. For instance, when a blood vessels become blocked, and blood supply to a part of the brain is lost, or a blood vessel can leak blood into the brain. However, the blockage can be caused by a blood clot that forms in the blood vessel (thrombosis) or it can be caused by a clot or debris that floats downstream.
The Global Transient Ischemic Attack Market is expected to grow at a CAGR of ~ 6.8% during the forecast period 2017-2023.
Increasing prevalence of neurological disorders, increasing investment of biotechnology and pharmaceutical industries in R&D, and rising need for the better treatment methods drives the growth of the market. Moreover, favorable reimbursement policies, increased application and significant investments in development of new technologies for the treatment of epilepsy, and other cardiac indications will fuel the market growth during the forecast period.
According to the WHO estimates, neurological disorders are responsible for 4.5%-11% of all disorders in the population including the low or high income economies. This is far higher as compared to the number of respiratory ailments, gastrointestinal disorders, or cancers, and the burden is expected to increase further over the coming years.
However, higher cost of these treatment procedure may hamper the market growth during the corresponding period. As per American Heart Association, currently costs approximately USD 20,000 which includes the cost of only one year and it is not affordable to the patients living in low income economies.
Some of key the players in the market are LivaNova PLC (U.K), EnteroMedics Inc. (U.S.), ElectroCore Medical LLC (U.S.), Boston Scientific Corporation (US), Cyberonics, Inc. (US), NeuroMetrix, Inc.(U.S.), ImThera Medical (U.S.), and Inspire Medical Systems, Inc.(U.S.), Nihon Kohden Corporation (Japan), Electrical Geodesics Inc. (U.S.), Masimo Corporation (U.S.), Hologic (U.S.), Esaote (Italy), and others.
Get Sample Copy @ https://www.marketresearchfuture.com/sample_request/5025 .
The global transient ischemic attack market has been segmented on the basis of diagnosis, treatment, and end user.
On the basis of diagnosis, the market is segmented into imaging technique and others. Imaging technique is further segmented into magnetic resonance angiography (MRA), CT angiography (CTA), carotid ultrasonography/transcranial doppler ultrasonography, and others.
On the basis of treatment, the market is segmented into surgery, antiplatelet medications, anticoagulant medications, and others. Surgery is further segmented into carotid endarterectomy and others. Antiplatelet medications is further segmented into clopidogrel, aspirin, and others. Anticoagulant medications is further segmented into warfarin, apixaban, and others.
On the basis of end user, the market is segmented into hospitals & clinics, research Laboratories, and others.
The Americas dominates the global transient ischemic attack market owing to well-developed technology, increasing prevalence neurological disorders, high healthcare spending, and increasing government support for research & development. Furthermore, increasing R&D activities and the presence of major companies have fuelled the growth of the market in this region.
Europe holds the second position in the global transient ischemic attack market. It is expected that the government support for research & development and availability of funds for research will drive the market in Europe region over the review period.
Asia Pacific is the fastest growing transient ischemic attack market owing to the presence of rapidly developing healthcare technology, huge patient population, and high healthcare expenditure. Moreover, increasing new opportunities in countries like China, India, Japan, and South Korea will make this as emerging and the fastest growing market across the globe. Furthermore, increasing demand for quality devices in the healthcare will lead to the use of advanced equipment, which, in turn, will increase the growth of the market in the region.
On the other hand, the Middle East & Africa holds the least share of the market due to limited availability of medical facilities, less availability of funds, and poor political conditions in Africa.
Table Of Content
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.2 Scope Of The Study
2.2.1 Research Objective
Chapter 3. Research Methodology
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
Apply for Discount@ https://www.marketresearchfuture.com/check-discount/5025 .
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Market Research Future
+1 646 845 9312